loading
Precedente Chiudi:
$1.31
Aprire:
$1.35
Volume 24 ore:
56,618
Relative Volume:
0.15
Capitalizzazione di mercato:
$11.59M
Reddito:
-
Utile/perdita netta:
$-26.23M
Rapporto P/E:
-1.0673
EPS:
-1.2274
Flusso di cassa netto:
$-10.29M
1 W Prestazione:
-2.99%
1M Prestazione:
-35.96%
6M Prestazione:
-68.29%
1 anno Prestazione:
-92.75%
Intervallo 1D:
Value
$1.28
$1.35
Intervallo di 1 settimana:
Value
$1.11
$1.43
Portata 52W:
Value
$1.11
$18.50

Seastar Medical Holding Corp Stock (ICU) Company Profile

Name
Nome
Seastar Medical Holding Corp
Name
Telefono
844-427-8100
Name
Indirizzo
3513 BRIGHTON BLVD, DENVER
Name
Dipendente
19
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
ICU's Discussions on Twitter

Confronta ICU con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ICU
Seastar Medical Holding Corp
1.315 11.59M 0 -26.23M -10.29M -1.2274
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.02 126.38B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
556.85 61.14B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
602.49 35.43B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
238.15 30.77B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
240.12 26.32B 3.81B -644.79M -669.77M -6.24

Seastar Medical Holding Corp Borsa (ICU) Ultime notizie

pulisher
Apr 10, 2025

ICU STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Seastar Medical Holding Corp. Investors with Losses Have Opportunity to Lead Class Action Lawsuit - ACCESS Newswire

Apr 10, 2025
pulisher
Apr 10, 2025

ICU stock hits 52-week low at $1.2 amid market challenges - Investing.com

Apr 10, 2025
pulisher
Apr 08, 2025

SeaStar Medical gains two new FDA breakthrough designations By Investing.com - Investing.com Australia

Apr 08, 2025
pulisher
Apr 08, 2025

SeaStar Medical gains two new FDA breakthrough designations - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

Major FDA Win: SeaStar's Revolutionary Therapy Targets 45,000 Cardiac Surgery Patients - Stock Titan

Apr 08, 2025
pulisher
Apr 03, 2025

Analyzing SeaStar Medical (NASDAQ:ICU) and Solventum (NYSE:SOLV) - Defense World

Apr 03, 2025
pulisher
Apr 01, 2025

ICU stock hits 52-week low at $1.5 amid market challenges - Investing.com

Apr 01, 2025
pulisher
Mar 29, 2025

SeaStar Medical reports USD 24.8 million loss in FY 2024 - Medical Buyer

Mar 29, 2025
pulisher
Mar 27, 2025

Earnings call transcript: SeaStar Medical sees stock dip after Q4 2024 - Investing.com India

Mar 27, 2025
pulisher
Mar 27, 2025

SeaStar Medical Holding Corp reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025
pulisher
Mar 27, 2025

SeaStar Medical Achieves Key Milestones: FDA-Approved Therapy Generates Initial Sales - Stock Titan

Mar 27, 2025
pulisher
Mar 25, 2025

SeaStar Medical Holding Corp expected to post a loss of 89 cents a shareEarnings Preview - TradingView

Mar 25, 2025
pulisher
Mar 25, 2025

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025 - The Manila Times

Mar 25, 2025
pulisher
Mar 18, 2025

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award - Quantisnow

Mar 18, 2025
pulisher
Mar 18, 2025

Groundbreaking Pediatric Kidney Treatment Earns SeaStar Medical Prestigious NKF Award - Stock Titan

Mar 18, 2025
pulisher
Mar 17, 2025

ICU INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Seastar Medical Holding Corp. to Contact the Firm Today! - ACCESS Newswire

Mar 17, 2025
pulisher
Mar 13, 2025

SeaStar Medical secures Nasdaq listing extension By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

SeaStar Medical secures Nasdaq listing extension - Investing.com India

Mar 13, 2025
pulisher
Feb 28, 2025

SeaStar Medical’s director John Neuman acquires $153,227 in shares By Investing.com - Investing.com Canada

Feb 28, 2025
pulisher
Feb 27, 2025

SeaStar Medical's director John Neuman acquires $153,227 in shares - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

SeaStar Medical’s director John Neuman acquires $153,227 in shares - Investing.com India

Feb 27, 2025
pulisher
Feb 27, 2025

ICU INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Seastar Medical Holding Corp. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 23, 2025

SeaStar Medical secures $6 million in direct offering - MSN

Feb 23, 2025
pulisher
Feb 21, 2025

SeaStar Medical (NASDAQ:ICU) versus OrthoPediatrics (NASDAQ:KIDS) Financial Review - Armenian Reporter

Feb 21, 2025
pulisher
Feb 19, 2025

Contrasting OrthoPediatrics (NASDAQ:KIDS) & SeaStar Medical (NASDAQ:ICU) - Defense World

Feb 19, 2025
pulisher
Feb 14, 2025

SeaStar Medical (NASDAQ:ICU) Stock Price Down 1.1% – Here’s Why - Defense World

Feb 14, 2025
pulisher
Feb 10, 2025

FINAL ICU DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Seastar Medical Holding Corp. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

Feb 10, 2025
pulisher
Feb 08, 2025

ICU Stockholders Have Opportunity to Lead Seastar Medical Holding Corp. Class Action LawsuitContact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire

Feb 08, 2025
pulisher
Feb 07, 2025

ICU STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman LLC Announces that Seastar Medical Holding Corp. Investors with Losses Have Opportunity to Lead Class Action Lawsuit - ACCESS Newswire

Feb 07, 2025
pulisher
Feb 05, 2025

Quarterly Metrics: Quick and Current Ratios for SeaStar Medical Holding Corp (ICU) - The Dwinnex

Feb 05, 2025
pulisher
Feb 04, 2025

How does SeaStar Medical Holding Corp (ICU) change from a tortoise to a hare? - SETE News

Feb 04, 2025
pulisher
Feb 04, 2025

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market - GlobeNewswire

Feb 04, 2025
pulisher
Feb 04, 2025

SeaStar Medical Holdings Corporation Enters Into $6 Million Securities Purchase AgreementDENVER (January 31, 2025) – In a move to bolster its financial positioning, SeaStar Medical Holdings Corporation (Nasdaq: ICU) disclosed that it has initiated a - Defense World

Feb 04, 2025
pulisher
Feb 04, 2025

SeaStar Medical announces $6M registered direct offering priced ATM - MSN

Feb 04, 2025
pulisher
Feb 03, 2025

Investing in SeaStar Medical Holding Corp (ICU): What You Must Know - Knox Daily

Feb 03, 2025
pulisher
Feb 03, 2025

Investing in Wimi Hologram Cloud Inc ADR (WIMI) Is Getting More Attractive - Knox Daily

Feb 03, 2025
pulisher
Feb 03, 2025

SeaStar Medical Secures $6M Through Equity Agreements - TipRanks

Feb 03, 2025
pulisher
Feb 03, 2025

SeaStar Medical Closes $6 Million Registered Direct Offering with Institutional Investor - Nasdaq

Feb 03, 2025
pulisher
Feb 03, 2025

Strategic $6M Capital Raise: SeaStar Medical Secures Institutional Backing with Warrant Sweetener - StockTitan

Feb 03, 2025
pulisher
Feb 03, 2025

ICU’s earnings forecast for the current quarter - US Post News

Feb 03, 2025
pulisher
Feb 03, 2025

ICU Stock: Exploring SeaStar Medical Holding Corp’s Growth - The InvestChronicle

Feb 03, 2025
pulisher
Feb 02, 2025

SeaStar Medical receives Nasdaq public reprimand - MSN

Feb 02, 2025
pulisher
Feb 02, 2025

SeaStar Medical Holding Co. (NASDAQ:ICUCW) Sees Significant Growth in Short Interest - Defense World

Feb 02, 2025
pulisher
Jan 31, 2025

SeaStar Medical Announces $6 Million Registered Direct Offering Priced At-the-Market - GlobeNewswire

Jan 31, 2025
pulisher
Jan 31, 2025

SeaStar Medical prices 3.53M shares at $1.70 in registered direct offering - TipRanks

Jan 31, 2025
pulisher
Jan 31, 2025

SeaStar Medical Raises Fresh Capital: $6M Strategic Investment Fuels Growth Plans - StockTitan

Jan 31, 2025

Seastar Medical Holding Corp Azioni (ICU) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Seastar Medical Holding Corp Azioni (ICU) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Neuman John
Director
Jun 17 '24
Buy
4.35
10,000
43,521
20,000
Neuman John
Director
Jun 14 '24
Buy
3.69
10,000
36,905
10,000
Neuman John
Director
Dec 11 '24
Buy
2.04
10,000
20,405
40,000
Chung Kevin
Chief Medical Officer
Nov 18 '24
Buy
1.99
4,250
8,458
13,685
Chung Kevin
Chief Medical Officer
Sep 30 '24
Buy
4.26
1,000
4,258
9,435
$19.12
price up icon 1.62%
$69.30
price up icon 1.40%
$32.04
price up icon 0.52%
$23.08
price up icon 0.13%
$99.03
price up icon 2.58%
biotechnology ONC
$246.22
price up icon 8.53%
Capitalizzazione:     |  Volume (24 ore):